Serum free light chain analysis and urine immunofixation electrophoresis in patients with multiple myeloma.
about
Appraisal of immunoglobulin free light chain as a marker of responseComment on "Clinical comparisons of two free light chain assays to immunofixation electrophoresis for detecting monoclonal gammopathy"Novel renal replacement strategies for the elimination of serum free light chains in patients with kappa light chain nephropathy.Patterns of relapse and progression in multiple myeloma patients after auto-SCT: implications for patients' monitoring after transplantation.Screening panels for detection of monoclonal gammopathies.Uncommon, sinister vertebral fracture: early-onset multiple myelomaCurrent trends in the diagnosis, therapy and monitoring of the monoclonal gammopathies.Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myelomaSerum free light chain analysis in the diagnosis and management of multiple myeloma and related conditions.The use of immunoglobulin light chain assays in the diagnosis of paraprotein-related kidney disease.The importance of screening for serum free light chains in suspected cases of multiple myeloma and their impact on the kidney.Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma.Serum-free light-chain analysis in diagnosis and management of multiple myeloma and related conditions.Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies.The spot urine protein/creatinine ratio is a simple, rapid and inexpensive method for monitoring patients with light-chain multiple myelomaThe association of serum-free light-chain levels with markers of renal function.Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease.Screening panels for monoclonal gammopathies: time to changeCutaneous and pleural involvement in a patient with multiple myelomaUtilisation of sFLC assays - how well do we comply with guidelines?Bence Jones proteinuria in smoldering multiple myeloma as a predictor marker of progression to symptomatic multiple myeloma.Increased sensitivity in detecting renal impairments by quantitative measurement of marker protein excretion compared to detection of pathological particles in urine sediment analysis.
P2860
Q24624398-497857E5-349C-4D63-B137-A891FA980755Q35226933-935C0D50-DF6C-443B-8DD8-258C254EE226Q35959002-C3993F5A-813D-4FD9-A676-BB29D5C879D1Q36675330-C6CD03D2-A4AB-4496-B9E2-FACD6942AB8DQ37172007-0B4906EF-1CDB-4AFB-9DAD-72934E2CC053Q37308586-D0B7A2C6-EEC9-420E-B4E3-86F245F1E245Q37370051-C15CACAF-9EB9-40CD-BE42-35241CCCD1C7Q37528072-7882657A-6AFF-4EBB-A4CD-A73B582F9C38Q38168869-0D104FB1-989B-4E5B-BF6F-9E100865DEFEQ38258148-0A0DF596-0818-4264-8470-1FCC36773CFBQ38261185-7839CB73-E628-4BD0-BFE7-167F9F725062Q38398899-C528A4DF-D1AD-4886-AAEF-C16990174E38Q38911216-757A1F5F-3A01-4174-A772-13BAB1C677ECQ38917341-F71E5193-7A04-4F5E-8058-DCD30DC60A43Q40332106-37A095F1-C3B4-4BE1-BF73-0B8836AEE7B2Q40855551-4186C3CD-BC15-408F-BDB2-0F5DEB32BD08Q41847394-026D07B5-1928-4915-973E-AD5A24E0961DQ42098619-CF71958C-FF1C-40E4-83FE-128A7445C4FBQ42242906-4A69628E-911E-41E9-A7C8-FD68CDAB5E92Q50898321-4A97A457-DF09-4C1D-A7CB-859462952EF2Q53109992-C0B5C8D2-D027-4297-8D3B-512B5A4D510FQ53801967-4AE3D19A-B6B5-4BED-B249-8683A5D91482
P2860
Serum free light chain analysis and urine immunofixation electrophoresis in patients with multiple myeloma.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Serum free light chain analysi ...... atients with multiple myeloma.
@ast
Serum free light chain analysi ...... atients with multiple myeloma.
@en
Serum free light chain analysi ...... atients with multiple myeloma.
@nl
type
label
Serum free light chain analysi ...... atients with multiple myeloma.
@ast
Serum free light chain analysi ...... atients with multiple myeloma.
@en
Serum free light chain analysi ...... atients with multiple myeloma.
@nl
prefLabel
Serum free light chain analysi ...... atients with multiple myeloma.
@ast
Serum free light chain analysi ...... atients with multiple myeloma.
@en
Serum free light chain analysi ...... atients with multiple myeloma.
@nl
P2093
P1476
Serum free light chain analysi ...... atients with multiple myeloma.
@en
P2093
Arthur R Bradwell
Bertram Opalka
Christiane Sammet
Dieter Brandhorst
Michael Flasshove
Michaela Kellert
Miriam Poser
Mohammad R Nowrousian
Peter Ebeling
P304
P356
10.1158/1078-0432.CCR-05-0486
P407
P433
P577
2005-12-01T00:00:00Z